Qu KS - Search Results

1

Qinzhuliangxue mixture alleviates psoriasis-like skin lesions via inhibiting the IL6/STAT3 axis.

Qu KS, Luo Y, Yan XN, Kuai L, Ru Y, Luo Y, Song JK, Ji WL, Li B, Xing M. Qu KS, et al. J Ethnopharmacol. 2021 Jun 28;274:114041. doi: 10.1016/j.jep.2021.114041. Epub 2021 Mar 20. J Ethnopharmacol. 2021. PMID: 33757812

2

A Reflection on the 2017 Nobel Prize for Physiology and Chinese Medicine.

Xing M, Qu KS, Huang Y, Xing YR. Xing M, et al. Among authors: qu ks. Chin J Integr Med. 2020 Nov;26(11):867-872. doi: 10.1007/s11655-018-2945-3. Epub 2019 Aug 5. Chin J Integr Med. 2020. PMID: 31385220

3

Buxuhuayu decoction accelerates angiogenesis by activating the PI3K-Akt-eNOS signalling pathway in a streptozotocin-induced diabetic ulcer rat model.

Qu K, Cha H, Ru Y, Que H, Xing M. Qu K, et al. J Ethnopharmacol. 2021 Jun 12;273:113824. doi: 10.1016/j.jep.2021.113824. Epub 2021 Feb 10. J Ethnopharmacol. 2021. PMID: 33581257 Free article.

4

Transcriptomic Analysis of the Mechanisms for Alleviating Psoriatic Dermatitis Using Taodan Granules in an Imiquimod-Induced Psoriasis-like Mouse Model.

Kuai L, Luo Y, Qu K, Ru Y, Luo Y, Ding X, Xing M, Liu L, Sun X, Li X, Li B. Kuai L, et al. Front Pharmacol. 2021 Apr 14;12:632414. doi: 10.3389/fphar.2021.632414. eCollection 2021. Front Pharmacol. 2021. PMID: 33995034 Free PMC article.

5

Epigenetics in psoriasis: perspective of DNA methylation.

Luo Y, Qu K, Kuai L, Ru Y, Huang K, Yan X, Xing M. Luo Y, et al. Mol Genet Genomics. 2021 Sep;296(5):1027-1040. doi: 10.1007/s00438-021-01804-y. Epub 2021 Jun 17. Mol Genet Genomics. 2021. PMID: 34137900 Review.

6

Fu-Huang ointment ameliorates impaired wound healing associated with diabetes through PI3K-AKT signalling pathway activation.

Qu KS, Ru Y, Yang D, Kuai L, Luo Y, Zhang PA, Xing M, Que HF. Qu KS, et al. Comput Biol Med. 2023 Mar;155:106660. doi: 10.1016/j.compbiomed.2023.106660. Epub 2023 Feb 10. Comput Biol Med. 2023. PMID: 36809697

7

Banzhilian formula alleviates psoriasis-like lesions via the LCN2/MMP-9 axis based on transcriptome analysis.

Xing M, Yan X, Guo J, Li W, Li Z, Dong C, Guo J, Qu K, Luo Y. Xing M, et al. Front Pharmacol. 2023 Mar 6;14:1055363. doi: 10.3389/fphar.2023.1055363. eCollection 2023. Front Pharmacol. 2023. PMID: 36950008 Free PMC article.

8

KangFuXin Liquid in the Treatment of Diabetic Foot Ulcer: A Systematic Review and Meta-Analysis.

Qu KS, Li Y, Liang Y, Hu XJ, Wang XY, Chen X, Que HF. Qu KS, et al. Evid Based Complement Alternat Med. 2019 Dec 30;2019:3678714. doi: 10.1155/2019/3678714. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31975998 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters